Literature DB >> 17975108

Förster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex.

Seth L Robia1, Kenneth S Campbell, Eileen M Kelly, Zhanjia Hou, Deborah L Winters, David D Thomas.   

Abstract

Phospholamban (PLB) or the sarcoplasmic reticulum Ca2+-ATPase (SERCA) were fused to cyan fluorescent protein (CFP) and coexpressed with PLB fused to yellow fluorescent protein (YFP). The expressed fluorescently tagged proteins were imaged using epifluorescence and total internal reflection fluorescence microscopy. YFP fluorescence was selectively bleached by a focused laser beam. CFP fluorescence at the targeted site increased after YFP photobleaching, indicating fluorescence resonance energy transfer between CFP-SERCA/CFP-PLB and YFP-PLB. The increased donor fluorescence relaxed back toward baseline as a result of donor diffusion and exchange of bleached YFP-PLB for unbleached YFP-PLB, which restored fluorescence resonance energy transfer. Requenching of CFP donors, termed Förster transfer recovery (FTR), was quantified as an index of the rate of PLB subunit exchange from the PLB:SERCA and PLB:PLB membrane complexes. PLB subunit exchange from the PLB:SERCA regulatory complex was rapid, showing diffusion-limited FTR (tau=1.4 second). Conversely, PLB:PLB oligomeric complexes were found to be stable on a much longer time scale. Despite free lateral diffusion in the membrane, they showed no FTR over 80 seconds. Mutation of PLB position 40 from isoleucine to alanine (I40A-PLB) did not abolish PLB:PLB energy transfer, but destabilization of the PLB:PLB complex was apparent from an increased FTR rate (tau=8.4 seconds). Oligomers of I40A-PLB were stabilized by oxidative crosslinking of transmembrane cysteines with diamide. We conclude that PLB exchanges rapidly from its regulatory complex with the SERCA pump, whereas subunit exchange from the PLB oligomeric complex is slow and does not occur on the time scale of the cardiac cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975108      PMCID: PMC2590498          DOI: 10.1161/CIRCRESAHA.107.159947

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  41 in total

1.  Solid-state NMR measurements of the kinetics of the interaction between phospholamban and Ca2+-ATPase in lipid bilayers.

Authors:  Eleri Hughes; David A Middleton
Journal:  Mol Membr Biol       Date:  2005 Jul-Aug       Impact factor: 2.857

Review 2.  Fanciful FRET.

Authors:  Steven S Vogel; Christopher Thaler; Srinagesh V Koushik
Journal:  Sci STKE       Date:  2006-04-18

3.  Human TRPC6 expressed in HEK 293 cells forms non-selective cation channels with limited Ca2+ permeability.

Authors:  Mark Estacion; William G Sinkins; Stephen W Jones; Milana A B Applegate; William P Schilling
Journal:  J Physiol       Date:  2006-01-26       Impact factor: 5.182

4.  Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals.

Authors:  David L Stokes; Andrew J Pomfret; William J Rice; John Paul Glaves; Howard S Young
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

5.  Effects of Ser16 phosphorylation on the allosteric transitions of phospholamban/Ca(2+)-ATPase complex.

Authors:  N J Traaseth; D D Thomas; G Veglia
Journal:  J Mol Biol       Date:  2006-03-07       Impact factor: 5.469

6.  Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA.

Authors:  Christine B Karim; Zhiwen Zhang; Edmund C Howard; Kurt D Torgersen; David D Thomas
Journal:  J Mol Biol       Date:  2006-03-09       Impact factor: 5.469

7.  A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban.

Authors:  M Li; L G Reddy; R Bennett; N D Silva; L R Jones; D D Thomas
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

8.  Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation.

Authors:  J Zamoon; F Nitu; C Karim; D D Thomas; G Veglia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

9.  Probing the oligomeric state of phospholamban variants in phospholipid bilayers from solid-state NMR measurements of rotational diffusion rates.

Authors:  Eleri Hughes; Jonathan C Clayton; David A Middleton
Journal:  Biochemistry       Date:  2005-03-15       Impact factor: 3.162

10.  Cross-linking of C-terminal residues of phospholamban to the Ca2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain.

Authors:  Zhenhui Chen; Brandy L Akin; David L Stokes; Larry R Jones
Journal:  J Biol Chem       Date:  2006-03-22       Impact factor: 5.157

View more
  36 in total

1.  Phospholamban mutants compete with wild type for SERCA binding in living cells.

Authors:  Simon J Gruber; Suzanne Haydon; David D Thomas
Journal:  Biochem Biophys Res Commun       Date:  2012-03-01       Impact factor: 3.575

2.  Phospholamban binds with differential affinity to calcium pump conformers.

Authors:  Philip Bidwell; Daniel J Blackwell; Zhanjia Hou; Aleksey V Zima; Seth L Robia
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

3.  Relative affinity of calcium pump isoforms for phospholamban quantified by fluorescence resonance energy transfer.

Authors:  Zhanjia Hou; Seth L Robia
Journal:  J Mol Biol       Date:  2010-07-17       Impact factor: 5.469

Review 4.  Nanoscale membrane organization: where biochemistry meets advanced microscopy.

Authors:  Alessandra Cambi; Diane S Lidke
Journal:  ACS Chem Biol       Date:  2011-11-14       Impact factor: 5.100

5.  Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells.

Authors:  Eileen M Kelly; Zhanjia Hou; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

6.  On the function of pentameric phospholamban: ion channel or storage form?

Authors:  Lucia Becucci; Alessandro Cembran; Christine B Karim; David D Thomas; Rolando Guidelli; Jiali Gao; Gianluigi Veglia
Journal:  Biophys J       Date:  2009-05-20       Impact factor: 4.033

7.  Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex.

Authors:  Zhanjia Hou; Eileen M Kelly; Seth L Robia
Journal:  J Biol Chem       Date:  2008-08-16       Impact factor: 5.157

8.  Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.

Authors:  Neha Abrol; Pieter P de Tombe; Seth L Robia
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

9.  Superinhibitory phospholamban mutants compete with Ca2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state.

Authors:  Brandy L Akin; Zhenhui Chen; Larry R Jones
Journal:  J Biol Chem       Date:  2010-07-11       Impact factor: 5.157

10.  Oligomeric interactions of sarcolipin and the Ca-ATPase.

Authors:  Joseph M Autry; John E Rubin; Sean D Pietrini; Deborah L Winters; Seth L Robia; David D Thomas
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.